Results 51 to 60 of about 4,798,414 (293)

Predicting Angiogenesis by Endothelial Progenitor Cells Relying on In-Vitro Function Assays and VEGFR-2 Expression Levels [PDF]

open access: yesBiomolecules, 2019
Clinical trials have demonstrated the safety and efficacy of autologous endothelial progenitor cell (EPC) therapy in various diseases. Since EPCs’ functions are influenced by genetic, systemic and environmental factors, the therapeutic potential of each individual EPCs is unknown and may affect treatment outcome.
Sabbah, Nadin   +5 more
openaire   +3 more sources

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Optimized conditions for radioligand binding and functional assays.

open access: yes, 2019
Optimized conditions for radioligand binding and functional assays.
Daniel Womer (6807767)   +4 more
core   +1 more source

Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3,4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays [PDF]

open access: yes, 2000
1-Keto-1,2,3,4-tetrahydrophenanthrene (THP-1) was reported by Cook et al in 1933 as the first synthetic estrogen. Estrogenic activity was assessed by the induction of vaginal cornification in ovariectomised rats.
Sumpter, JP   +5 more
core   +1 more source

Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens

open access: yesVaccines, 2019
The preferred product characteristics (for chemistry, control, and manufacture), in addition to safety and efficacy, are quintessential requirements for any successful therapeutic.
Cristina Poveda   +3 more
doaj   +1 more source

Meta‐analysis of massively parallel reporter assays enables prediction of regulatory function across cell types [PDF]

open access: yesHuman Mutation, 2019
Deciphering the potential of noncoding loci to influence gene regulation has been the subject of intense research, with important implications in understanding genetic underpinnings of human diseases. Massively parallel reporter assays (MPRAs) can measure regulatory activity of thousands of DNA sequences and their variants in a single experiment.
Anat Kreimer   +3 more
openaire   +4 more sources

Reconstructing enzyme evolution by protein engineering

open access: yesFEBS Letters, EarlyView.
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler   +2 more
wiley   +1 more source

Functional assays in marine biotoxin detection

open access: yes, 2005
The contamination of seafood by algal toxins regularly affects animals living in several areas of the world, and the number of toxic phycotoxins which are being characterized is steadily increasing.
ROSSINI, Gian Paolo
core   +1 more source

Predictive Coding or Evidence Accumulation? False Inference and Neuronal Fluctuations [PDF]

open access: yes, 2010
Perceptual decisions can be made when sensory input affords an inference about what generated that input. Here, we report findings from two independent perceptual experiments conducted during functional magnetic resonance imaging (fMRI) with a sparse ...
Andreas Kleinschmidt   +11 more
core   +2 more sources

Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays

open access: yes, 2021
International audienceWithin the past few years, poly (ADP-ribose) polymerase inhibitors (PARPi) have been added to the standard of care for cancer patients, mainly for those exhibiting specific genomic alterations in the homologous recombination (HR ...
Poulain, Laurent   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy